Amarin Corp Plc (AMRN)

[Birdbrain Ideas]

Pardon my ignorance, but isn't it true that this marketing authorization in England doesn't really speed anything up?

For instance, it doesn't thrust the U.K. into the Germany setup where sales can quickly begin.

In fact, it means only that the negotiations over pricing that presumably are going on with each European country prior to the start of Vascepa sales can now begin with England too. And can't that take up to a year to settle before sales launch?

So perhaps this announcement today just catches up England to the rest of the countries in Europe that were recently approved for sales. Because of Brexit, Great Britain must follow the European Commission and quickly approve drug applications on their own after the European Commission does or they'll be left behind.

By the way, I'd love for somebody with knowledge to tell me my assumptions are totally wrong, if they are. In my dream world, I'd like to imagine that Amarin announces next week that sales will begin in England in the third or fourth quarter.